<VariationArchive VariationID="2951021" VariationName="NM_001374353.1(GLI2):c.2651del (p.Pro884fs)" VariationType="Deletion" Accession="VCV002951021" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3109924" VariationID="2951021">
      <GeneList>
        <Gene Symbol="GLI2" FullName="GLI family zinc finger 2" GeneID="2736" HGNC_ID="HGNC:4318" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120735868" stop="120992653" display_start="120735868" display_stop="120992653" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121554866" stop="121750228" display_start="121554866" display_stop="121750228" Strand="+" />
          </Location>
          <OMIM>165230</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001374353.1(GLI2):c.2651del (p.Pro884fs)</Name>
      <CanonicalSPDI>NC_000002.12:120988610:CCCCCC:CCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120988611" stop="120988611" display_start="120988611" display_stop="120988611" variantLength="1" positionVCF="120988610" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121746187" stop="121746187" display_start="121746187" display_stop="121746187" variantLength="1" positionVCF="121746186" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>P759fs</ProteinChange>
      <ProteinChange>P901fs</ProteinChange>
      <ProteinChange>P884fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.121746192del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.121746192del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.120988616del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.120988616del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009030.1" sequenceAccession="NG_009030" sequenceVersion="1" change="g.196326del">
            <Expression>NG_009030.1:g.196326del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009030.2" sequenceAccession="NG_009030" sequenceVersion="2" change="g.257750del">
            <Expression>NG_009030.2:g.257750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371271.1" sequenceAccession="NM_001371271" sequenceVersion="1" change="c.2702del">
            <Expression>NM_001371271.1:c.2702del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358200.1" sequenceAccession="NP_001358200" sequenceVersion="1" change="p.Pro901fs">
            <Expression>NP_001358200.1:p.Pro901fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374353.1" sequenceAccession="NM_001374353" sequenceVersion="1" change="c.2651del" MANESelect="true">
            <Expression>NM_001374353.1:c.2651del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361282.1" sequenceAccession="NP_001361282" sequenceVersion="1" change="p.Pro884fs">
            <Expression>NP_001361282.1:p.Pro884fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374354.1" sequenceAccession="NM_001374354" sequenceVersion="1" change="c.2276del">
            <Expression>NM_001374354.1:c.2276del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361283.1" sequenceAccession="NP_001361283" sequenceVersion="1" change="p.Pro759fs">
            <Expression>NP_001361283.1:p.Pro759fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005270.5" sequenceAccession="NM_005270" sequenceVersion="5" change="c.2702del">
            <Expression>NM_005270.5:c.2702del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005261.2" sequenceAccession="NP_005261" sequenceVersion="2" change="p.Pro901fs">
            <Expression>NP_005261.2:p.Pro901fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001374353.1(GLI2):c.2651del (p.Pro884fs) AND multiple conditions" Accession="RCV003802283" Version="1">
        <ClassifiedConditionList TraitSetID="19333">
          <ClassifiedCondition DB="MedGen" ID="C1835819">Holoprosencephaly 9</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4014479">Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="19333" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="13797" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Culler-Jones syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome</ElementValue>
                <XRef ID="MONDO:0014369" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CJS</ElementValue>
                <XRef Type="MIM" ID="615849" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHS2</ElementValue>
                <XRef Type="MIM" ID="615849" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13349" />
                <XRef ID="13349" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="420584" DB="Orphanet" />
              <XRef ID="C4014479" DB="MedGen" />
              <XRef ID="MONDO:0014369" DB="MONDO" />
              <XRef Type="MIM" ID="615849" DB="OMIM" />
            </Trait>
            <Trait ID="5262" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Holoprosencephaly 9</ElementValue>
                <XRef ID="Holoprosencephaly+9/8564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012563" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPE9</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301702</ID>
                <ID Source="BookShelf">NBK1530</ID>
              </Citation>
              <XRef ID="2162" DB="Orphanet" />
              <XRef ID="C1835819" DB="MedGen" />
              <XRef ID="MONDO:0012563" DB="MONDO" />
              <XRef Type="MIM" ID="610829" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8562710" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="26694831|MedGen:C4014479;C1835819" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004608875" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro901Argfs*11) in the GLI2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 686 amino acid(s) of the GLI2 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GLI2-related conditions. This variant disrupts a region of the GLI2 protein in which other variant(s) (p.Gln1206Hisfs*14) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLI2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.121746187del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014479" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1835819" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8562710" TraitType="Disease" MappingType="XRef" MappingValue="C4014479" MappingRef="MedGen">
        <MedGen CUI="C4014479" Name="Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8562710" TraitType="Disease" MappingType="XRef" MappingValue="C1835819" MappingRef="MedGen">
        <MedGen CUI="C1835819" Name="Holoprosencephaly 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

